Location History:
- Longueuil, CA (2010 - 2011)
- Beaconsfield, CA (2009 - 2023)
Company Filing History:
15 out of 17 
3 out of 11 
1 out of 12 Years Active: 2009-2025
Title: The Innovative Contributions of Inventor Michel Demeule
Introduction: Michel Demeule, based in Beaconsfield, CA, is a distinguished inventor known for his significant contributions to the fields of biomedical research and patent innovation. With an impressive portfolio of 20 patents, Demeule has focused much of his work on developing peptide compounds aimed at tackling critical health issues, particularly cancer treatment.
Latest Patents: Demeule's latest patents are centered around the creation of peptide compounds and conjugates specifically designed for the treatment of cancer through receptor-mediated chemotherapy. These innovative compounds aim to enhance the effectiveness of chemotherapy by increasing the cellular internalization of the peptide compounds. Notable examples of the compounds developed by Demeule include specific sequences such as GVRAKAGVRNMFKSESY (SEQ ID NO: 9), GVRAKAGVRN(Nle)FKSESY (SEQ ID NO: 10), and YKSLRRKAPRWDAPLRDPALRQLL (SEQ ID NO: 11). Each of these compounds involves at least one protecting group and/or at least one labeling agent attached to the peptide compound, showcasing Demeule's analytical and inventive prowess.
Career Highlights: Throughout his career, Michel Demeule has been an integral part of various biotech companies, including Angiochem Inc. and Transfert Plus, S.E.C. His dedication to advancing healthcare solutions through innovative research has positioned him as a leader in his field, particularly in the domain of peptide therapeutics.
Collaborations: Demeule's work has often been enhanced through collaborations with talented professionals, including peers like Christian Che and Richard Béliveau. These partnerships not only reflect his teamwork approach but also emphasize the importance of multidisciplinary efforts in driving forward innovations in cancer treatment.
Conclusion: Michel Demeule continues to make remarkable strides in the field of peptide research, utilizing innovation to address pressing medical challenges. His substantial number of patents and collaborative spirit are testaments to his dedication and expertise as an inventor, paving the way for future breakthroughs in medicine.